Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

orion laboratories pty ltd t/a perrigo australia - nicotine, quantity: 4 mg - gum, chewing - excipient ingredients: saccharin; sodium bicarbonate; purified water; sorbitol; mannitol; saccharin sodium; menthol; acesulfame potassium; glycerol; calcium carbonate; carnauba wax; xylitol; sodium carbonate; gelatin; polacrilin; titanium dioxide; synthetic terpene resin; polyvinyl acetate; mono- and di- glycerides; flavour - an aid in the cessation of smoking in smokers with nicotine dependence. nicotinell coated chewing gums may also be used as part of a smoking reduction strategy by smokers who are unable or not ready to stop smoking abruptly as a step towards stopping completely.

Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

orion laboratories pty ltd t/a perrigo australia - nicotine, quantity: 2 mg - gum, chewing - excipient ingredients: saccharin sodium; calcium carbonate; carnauba wax; glycerol; purified water; saccharin; sorbitol; polacrilin; gelatin; sodium bicarbonate; sodium carbonate; titanium dioxide; acesulfame potassium; xylitol; mannitol; menthol; flavour; synthetic terpene resin; polyvinyl acetate; mono- and di- glycerides - an aid in the cessation of smoking in smokers with nicotine dependence. nicotinell coated chewing gums may also be used as part of a smoking reduction strategy by smokers who are unable or not ready to stop smoking abruptly as a step towards stopping completely.

Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

johnson & johnson pacific pty ltd - nicotine polacrilex, quantity: 20 mg (equivalent: nicotine, qty 4 mg) - gum, chewing - excipient ingredients: carnauba wax; xylitol; quinoline yellow aluminium lake; peppermint oil; acacia; menthol; light magnesium oxide; sodium carbonate; acesulfame potassium; titanium dioxide; calcium carbonate; butylated hydroxytoluene; isobutylene/isoprene copolymer; polyisobutylene; polyethylene; polyvinyl acetate; synthetic terpene resin; microcrystalline wax; mono- and di- glycerides - for the treatment of tobacco dependence by relieving nicotine craving and withdrawal symptoms thus facilitating smoking cessation in smokers motivated to quit. in smokers unable or not ready to stop smoking abruptly, the inhaler or gum may also be used as part of a smoking reduction strategy as a step towards stopping completely.

Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

johnson & johnson pacific pty ltd - nicotine polacrilex, quantity: 10 mg (equivalent: nicotine, qty 2 mg) - gum, chewing - excipient ingredients: titanium dioxide; sodium bicarbonate; acacia; menthol; acesulfame potassium; light magnesium oxide; peppermint oil; carnauba wax; xylitol; sodium carbonate; calcium carbonate; butylated hydroxytoluene; isobutylene/isoprene copolymer; polyisobutylene; polyethylene; polyvinyl acetate; synthetic terpene resin; microcrystalline wax; mono- and di- glycerides - for the treatment of tobacco dependence by relieving nicotine craving and withdrawal symptoms thus facilitating smoking cessation in smokers motivated to quit. in smokers unable or not ready to stop smoking abruptly, the inhaler or gum may also be used as part of a smoking reduction strategy as a step towards stopping completely.

Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

johnson & johnson pacific pty ltd - nicotine polacrilex, quantity: 10 mg - gum, chewing - excipient ingredients: xylitol; peppermint oil; acesulfame potassium; sodium bicarbonate; hypromellose; pregelatinised maize starch; carnauba wax; sodium carbonate; light magnesium oxide; titanium dioxide; polysorbate 80; sucralose; menthol; flavour; calcium carbonate; butylated hydroxytoluene; isobutylene/isoprene copolymer; polyisobutylene; polyethylene; polyvinyl acetate; synthetic terpene resin; microcrystalline wax; mono- and di- glycerides - for the treatment of tobacco dependence by relieving nicotine craving and withdrawal symptoms, thereby facilitating smoking cessation in smokers,motivated to quit. in smokers unable or not ready to stop smoking abruptly, the inhaler or gum may also be used as part of a smoking reduction strategy,as a step towards stopping completely.

Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

johnson & johnson pacific pty ltd - nicotine polacrilex, quantity: 20 mg - gum, chewing - excipient ingredients: peppermint oil; titanium dioxide; sucralose; carnauba wax; pregelatinised maize starch; hypromellose; acesulfame potassium; quinoline yellow aluminium lake; menthol; polysorbate 80; xylitol; light magnesium oxide; sodium carbonate; calcium carbonate; butylated hydroxytoluene; isobutylene/isoprene copolymer; polyisobutylene; polyethylene; polyvinyl acetate; synthetic terpene resin; microcrystalline wax; mono- and di- glycerides; flavour - for the treatment of tobacco dependence by relieving nicotine craving and withdrawal symptoms, thereby facilitating smoking cessation in smokers,motivated to quit. in smokers unable or not ready to stop smoking abruptly, the inhaler or gum may also be used as part of a smoking reduction strategy,as a step towards stopping completely.

Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

johnson & johnson pacific pty ltd - nicotine polacrilex, quantity: 20 mg (equivalent: nicotine, qty 4 mg) - gum, chewing - excipient ingredients: glycerol; sorbitol; quinoline yellow; sodium carbonate; flavour; calcium carbonate; butylated hydroxytoluene; isobutylene/isoprene copolymer; polyisobutylene; polyethylene; polyvinyl acetate; glycerol ester of gum rosin; glycerol ester of polymerised rosin; microcrystalline wax; mono- and di- glycerides - for the treatment of tobacco dependence by relieving nicotine craving and withdrawal symptoms thus facilitating smoking cessation in smokers motivated to quit. in smokers unable or not ready to stop smoking abruptly, the inhaler or gum may also be used as part of a smoking reduction strategy as a step towards stopping completely.

Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

johnson & johnson pacific pty ltd - nicotine polacrilex, quantity: 10 mg (equivalent: nicotine, qty 2 mg) - gum, chewing - excipient ingredients: glycerol; sodium carbonate; sorbitol; sodium bicarbonate; flavour; calcium carbonate; butylated hydroxytoluene; isobutylene/isoprene copolymer; polyisobutylene; polyethylene; polyvinyl acetate; glycerol ester of gum rosin; glycerol ester of polymerised rosin; microcrystalline wax; mono- and di- glycerides - for the treatment of tobacco dependence by relieving nicotine craving and withdrawal symptoms thus facilitating smoking cessation in smokers motivated to quit. in smokers unable or not ready to stop smoking abruptly, the inhaler or gum may also be used as part of a smoking reduction strategy as a step towards stopping completely.

Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

johnson & johnson pacific pty ltd - nicotine polacrilex, quantity: 20 mg - gum, chewing - excipient ingredients: hypromellose; quinoline yellow aluminium lake; xylitol; acacia; carnauba wax; acesulfame potassium; polysorbate 80; menthol; light magnesium oxide; sodium carbonate; titanium dioxide; peppermint oil; sucralose; flavour; calcium carbonate; butylated hydroxytoluene; isobutylene/isoprene copolymer; polyisobutylene; polyethylene; polyvinyl acetate; synthetic terpene resin; microcrystalline wax; mono- and di- glycerides - for the treatment of tobacco dependence by relieving nicotine craving and withdrawal symptoms, thereby facilitaing smoking cessation in smokers,motivated to quit. in smokers unable or not ready to stop smoking abruptly, the inhaler or gum may also be used as part of a smoking reduction strategy,as a step towards stopping completely.

Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

johnson & johnson pacific pty ltd - nicotine polacrilex, quantity: 10 mg - gum, chewing - excipient ingredients: hypromellose; acesulfame potassium; peppermint oil; xylitol; polysorbate 80; acacia; titanium dioxide; carnauba wax; sucralose; menthol; sodium carbonate; sodium bicarbonate; light magnesium oxide; calcium carbonate; butylated hydroxytoluene; isobutylene/isoprene copolymer; polyisobutylene; polyethylene; polyvinyl acetate; synthetic terpene resin; microcrystalline wax; mono- and di- glycerides; flavour - for the treatment of tobacco dependence by relieving nicotine craving and withdrawal symptoms, thereby facilitaing smoking cessation in smokers,motivated to quit. in smokers unable or not ready to stop smoking abruptly, the inhaler or gum may also be used as part of a smoking reduction strategy,as a step towards stopping completely.